Pfizer first revealed plans to try to develop an antiviral compound for COVID-19 in March, and later said it was working with BioNTech SE on a potential vaccine based on messenger RNA technology.
Source: Today Deals
Pfizer first revealed plans to try to develop an antiviral compound for COVID-19 in March, and later said it was working with BioNTech SE on a potential vaccine based on messenger RNA technology.
Source: Today Deals